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The spectrum of kidney disease in American Indians. American of 27.8 years (vs. 35.8 years for the U.S. all races), and
Indians and Alaska Natives (AI/AN) experience high rates relatively poor with 32% living below the poverty rate
of chronic kidney disease. Several studies have demonstrated (vs. 13.1% of the US population). Unemployment isincreased rates of early kidney disease among AI/AN, both in
twice as high as and income two thirds of that of thediabetics and non-diabetics. Among some tribes of the Ameri-
rest of the country; the high school dropout rate is 35%can Southwest, high rates of mesangiopathic glomerulonephri-
tis have been documented. The epidemic of diabetes among compared with 25% for the general population [1].
AI/AN, which began in the middle of the 20th century, appears During the past few decades the disease burden among
to be driving the increase in end-stage renal disease (ESRD). AI/AN has shifted from acute infectious diseases toAt the end of 1999, AI/AN had a national prevalence rate of
chronic illnesses, particularly type 2 diabetes and its com-treated ESRD that was 3.5 times greater than that of white
plications. Diabetes, virtually unknown among AI/ANAmericans. There is significant regional variation as well as
differences among the approximately 550 tribes that make up people prior to World War II, is a problem of epidemic
the American Indian community, with some tribes experienc- proportions among the native people of North America.
ing ESRD rates over twenty times the rate of whites. Although
Diabetes prevalence among AI/AN aged 20 to 44 years,graft survival is excellent, AI/AN ESRD patients are less likely
45 to 64 years, and over 65 years is 3.5%, 19%, andthan whites to be placed on the transplant waiting list, and
those listed wait longer for a transplant. Despite socioeconomic 21.5%, respectively, 2.8 times the rate of diabetes among
barriers and high rates of co-morbid illness, survival among US non-Hispanic whites [2]. Nine percent of all AI/AN
AI/AN ESRD patients is better than among whites. The burden aged 20 years and older are diabetic. In some tribes (for
of kidney disease, particularly the multigenerational occur-
example, Pima, Zuni), 30 to 50% of the population isrence in some families, is perceived as a major threat to the
diabetic. Among Navajo people aged over 45 years 40%well-being of native communities. There is a sense of urgency
among tribal leaders to address this epidemic, and research are diabetic [3]. The incidence continues to rise among
that may decrease its burden is likely to be welcomed. all age groups, but this rise is most alarming in adoles-
cents and young adults. From 1991 to 1997 the diabetes
prevalence among AI/AN aged 15 to 19 years increased
Approximately 2.5 million people identified them- 32% [4]. Diabetes mortality among AI/AN (39.4/100,000
selves as American Indian or Alaska Native (AI/AN) in population) is three times higher than in the US popula-
the 2000 United States census. The AI/AN population tion (13.3/100,000 population).
includes members of over 550 federally recognized tribes, Most AI/AN people living on reservations and some
representing diverse cultural traditions and lifestyles. who live in urban centers receive their health care through
Approximately 38% of AI/AN live on rural reservations, the Indian Health Service (IHS), an agency of the US
mostly in the western United States (US), and 22% live Public Health Service. The IHS is the principal federal
near reservations. Tribes function as sovereign nations health care provider and health advocate for Indian peo-
and relate to the US federal government on a nation- ple. Its goal is to raise their health status to the highest
to-nation basis. The Navajo Nation is the largest tribe, possible level. The provision of health services to mem-
with 250,000 members, and a reservation in northern bers of federally recognized tribes grew out of the special
Arizona, western New Mexico, and southern Utah that government-to-government relationship between the
covers more than 25,000 square miles. The American federal government and Indian tribes. The IHS currently
Indian population is relatively young, with a median age provides health services to approximately 1.5 million
people with a budget of approximately 2.5 billion dollars.
1 The opinions expressed in this article are those of the author and do IHS services are provided directly and also through trib-
not necessarily reflect the views of the Indian Health Service. ally contracted and operated health programs. Health
services also include health care purchased from moreKey words: Native Americans, kidney diseases, kidney failure, chronic
renal disease, renal transplantation. than two thousand private providers. As of October 1998,
the Federal system consisted of 37 hospitals, 59 health 2003 by the International Society of Nephrology
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centers, 44 health stations, and four school health cen- with ESRD living on reservations, primarily in Arizona
and New Mexico [6]. While the overall US rate of treatedters. Of 151 service units, 85 were operated by Tribes.
In addition, 36 urban Indian health projects provide a ESRD was 3.2 times greater among AI/AN than among
whites, in the Southwest the AI rate was 6.5 times greater.variety of health and referral services. Tribal health pro-
grams also provide comprehensive preventive and cura- Ninety-two percent (92%) of these Southwest ESRD
patients were full-blood quantum AI/AN (all four grand-tive services. As of March 1996, American Indian tribes
and Alaska Native corporations administered 12 hospi- parents are AI/AN). Among Southwest AI, over 80%
of incident ESRD is due to diabetes. At the end of thetals, 116 health centers, three school health centers, 56
health stations, and 167 Alaska village clinics. year 2000 the Navajo Nation had over 550 ESRD pa-
tients, more than any other tribe.
Some communities of the Southwest have extraordi-
BURDEN OF RENAL DISEASE
narily high rates of kidney failure. In Zuni Pueblo, a com-
End-stage renal disease munity of 10,000 in western New Mexico, the prevalence
of ESRD is 17,400 per million population [7]. This isAmerican Indians and Alaska Natives experience high
rates of end-stage renal disease (ESRD). At the end of 4.5-, 5.7-, and 21.3-fold higher than that for African
Americans, American Indians, and European Ameri-1999, 5361 people identified as AI/AN were being treated
for ESRD, reflecting a prevalence 3.5 times greater than cans, respectively. Approximately 2% (100 persons) of
the adults aged 21 years and older in the Zuni populationthat of white Americans [5]. The incidence for ESRD
was 2.7 times the white rate and increased at 8% per have treated ESRD. With rates this high, virtually every
family has an affected member.year during the period of 1992 to 1996. During the
10-year period from 1988 to 1997 the number of AI/AN
Chronic kidney diseasewith ESRD tripled. The epidemic of diabetes among
AI/AN, which began in the middle of the 20th century, End-stage renal disease rates are but one reflection of
the burden of kidney disease; the rate of renal diseaseappears to be driving the increase in ESRD. More than
two thirds (68%) of AI/AN who initiated treatment for less than end-stage is more difficult to determine. Several
studies have demonstrated increased rates of early kid-ESRD in 1999 developed kidney failure as a result of
diabetes, virtually all type 2, while only 25% of whites ney disease among AI/AN, both in diabetics and non-
diabetics. The Strong Heart Study, a longitudinal studyand 42% of blacks with ESRD were diabetic. The inci-
dence for ESRD due to type 2 diabetes among AI/AN to measure risk factors for cardiovascular disease among
American Indians from three geographic sites (Arizona,during 1996 to 1999 (349/million) was three times the
white rate (99/million), and higher than any other dis- North and South Dakota, and Oklahoma) has demon-
strated high rates of abnormal albumin excretion (20.1ease-specific rate for any US race. The incidence was sub-
stantially higher in AI/AN women (394/million) than in to 48.3%) in all tribes studied [8]. Although the preva-
lence of diabetes was 53% in the study population, per-men (304/million). In addition to those whose primary
renal diagnosis is diabetic nephropathy, many persons sons without diabetes also had high rates (10 to 20%)
of abnormal albuminuria. Among both diabetics andwith ESRD due to non-diabetic kidney disease subse-
quently develop diabetes. Consistent with the early on- non-diabetics abnormal albumin excretion was associ-
ated with increased blood quantum (degree of Indianset of type 2 diabetes among native people, the mean
age of onset of ESRD for AI/AN is 57 years, six years heritage), suggesting a genetic basis for susceptibility to
renal injury. The Zuni Kidney Project, a population-younger than for whites (63 years).
The rates cited above describe the burden of ESRD based, cross-sectional survey of the Pueblo of Zuni also
has demonstrated albuminuria in 20% of the population,among all persons in the United States identified by their
treatment facility as AI/AN. As alarming as these na- only half of whom are diabetic [7].
Determining the burden of non-diabetic renal diseasetional rates are, they mask significant regional variation
as well as differences among the approximately 550 tribes is problematic in a population where 30 to 50% of the
adult population may be diabetic, because many casesthat make up the American Indian community. Analysis
of 1994 data from ESRD Network #15 and the IHS shows of non-diabetic renal disease also may have diabetes as
a co-morbid condition. In these cases nephrologic evalu-that the burden of kidney failure is much higher among
AI/AN of the Southwest, who receive their care from ation might be delayed until late in the course of the
renal injury, when biopsy is no longer a consideration,IHS, than it is among the US population or the national
AI/AN population. ESRD Network #15, which collects and physicians may incorrectly assume that the primary
cause of the renal failure is diabetes.data from the Southwest (Arizona, New Mexico, Colo-
rado, Utah, Wyoming, and Nevada), includes more than The prevalence and natural history of non-diabetic
kidney disease among AI of the Southwest has been the30% of the AI/AN identified in the US Renal Data
System (USRDS) database and a plurality of the AI/AN subject of several published reports over the past 20 years.
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Studies of Zuni Pueblo during the 1980’s reported high tions, high rates of poverty, difficulty in recruiting and
retaining staff in outlying areas, language and culturalrates of mesangiopathic glomerulonephritis (MesGN),
predominantly IgA, and documented pedigrees of sev- differences, and the high numbers of patients with diabe-
tes and extra-renal diabetic complications. A recent sur-eral families with multiple members affected in different
generations [9]. A biopsy series from 44 Zuni people vey of the 524 AI/AN dialysis patients aged 20 to 60
years living in Arizona and New Mexico revealed thatwith non-diabetic renal disease included 34 (77%) with
MesGN. Immunoglobulins and complement and well- 80% lived on a reservation, 31% had only an elementary
education, 73% did not speak English at home, and 56%defined electron-dense deposits were present in the mes-
angium in half these cases. IgM, IgA, IgG, and C3 were traveled more than an hour each way for dialysis treat-
ment. Common co-morbid conditions included diabetesvariably represented. A review of all AI renal biopsies
processed at the University of New Mexico Health Sci- (73%), hypertension (83%), peripheral vascular disease
(44%), blindness (30%), and liver disease (10%) [13].ences Center from 1971 to 1989 included 166 specimens;
64 of these were from Zuni. Immunoglobulin-positive
MesGN, mesangial expansion and/or mesangial cell pro-
ACCESS TO TRANSPLANTATION
liferation, together with mesangial immune deposits were
At the end of 1999, only 22% (1181) of the AI/ANdiagnosed in 78% of the Zuni specimens. Nearly 40%
ESRD population had functioning transplants, com-showed cellular crescents [10]. The majority showed inter-
pared with 36% of white US ESRD patients. The rateposition of mesangial matrix material into the glomerular
of renal transplants for the treated AI/AN ESRD wascapillary walls, glomerulosclerosis, interstitial fibrosis, and
0.7 transplants/100 patient-years on dialysis, while thetubular atrophy. Although these reports and anecdotal
rate for white patients was 1.8 transplants/100 patient-clinical reports suggest high rates of glomerulonephritis
years on dialysis. Transplant rates among diabetic ESRDamong both the Zuni and other tribes, the Zuni Kidney
patients are similarly disproportionate: 0.4/100 patient-Project is the first population-based investigation of the
years on dialysis for AI/AN and 0.9 for US whites. Ac-burden of non-diabetic renal disease in an AI/AN com-
cording to the Health Care Financing Administrationmunity.
AI/AN ESRD patients are less likely than whites to beThe burden of nephropathy among diabetics has been
placed on the transplant waiting list, and those listedmonitored for several years by the IHS Diabetes Pro-
wait longer for a transplant. Similar results were foundgram through a yearly chart audit [11], which includes
in studies by ESRD Network #15 of AI/AN ESRD pa-measures of renal function and abnormal protein excre-
tients in Arizona and New Mexico, who have lower trans-tion. In 1999, 13,248 charts were randomly selected for
plant rates than whites in both states, even when rates areaudit from the 80,827 persons enrolled in the IHS Diabetes
adjusted for diagnosis and age [13]. Delays in completingRegistry. Although only 3% of these diabetics had a creat-
transplant evaluations play a significant role in the lowinine greater than two, nearly 50% had significant loss of
access to transplantation for at least some racial andrenal function based on a calculated creatinine clearance:
economic minorities. ESRD Network #15 and the IHS2% with less than 20 mL/min, 19% with 20 to 59, 22%
examined socio-demographic factors, ESRD treatment,with 60 to 80, and 45% with 80 mL/min. Abnormal
co-morbidities, and transplant candidacy status to deter-protein excretion was present in 33% of the patients,
mine the factors that contribute to candidacy and whe-10% with microalbuminuria and 23% with overt protein-
ther the AI/AN ESRD population experiences barriersuria. Hypertension was present in 77% of those with overt
not encountered by the white population. Using six dif-proteinuria and 69% of those with microalbuminuria.
ferent criteria, they showed that the rates of candidacy
for AI/AN and white ESRD patients were about the same
TREATMENT OF ESRD by every definition except the most stringent: awaiting
transplant. Thus, AI/AN are referred for transplant atFor many tribes, the epidemic burden of ESRD has
become a community-wide problem, and significant ef- similar rates as white patients, but experience a greater
delay before transplantation.forts have gone into establishing dialysis services on res-
ervations. The first on-reservation dialysis unit was estab- The major barriers to transplantation for AI/AN ESRD
patients lie in the process of fulfilling requirements andlished at Shiprock, New Mexico in 1979. At the end of
2000 there were over 30 dialysis units on or near reserva- in the availability of matching kidneys. Data obtained
from the United Network for Organ Sharing (UNOS)tions serving predominantly AI/AN patients [12]. Al-
though reservation-based dialysis units have improved indicate that the Kaplan-Meier median waiting time to
transplant for patients from Arizona and New Mexicothe access of patients to renal replacement therapy, enor-
mous barriers to improving care remain. These include listed during 1997 through 1999 was 1306 days for AI/AN
and 929 days for whites. After six months on the waitingthe rural and frequently isolated settings where travel
to facilities is made difficult by distance and road condi- list 6.2% of the AI/AN patients and 11.1% of white pa-
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tients had received a transplant. Although a higher pro- and blood pressure was controlled in 62%: 16% achieved
portion of AI transplant recipients in ESRD Network “Ideal BP Control” (120/80 mm Hg), 22% “Target”
#15 have a living-related donor allograft than white recip- BP (120 to 130/80 to 85 mm Hg), and 24% “Ade-
ients, cadaver donation from AI/AN remains a rare event. quate Control” (130/85 to 140/90 mm Hg). Approxi-
Significant cultural barriers will have to be overcome to mately 30% had “Inadequate” control (140/90 to 160/
increase the donation rate. 95 mm Hg) and 8% had markedly poor control (160/
Unlike African Americans, another racial minority 95 mm Hg or higher). In aggregate, blood pressure was
with low transplant rates, graft survival in AI/AN com- controlled in 62% of diabetics compared to 27% of the
pares favorably with that of whites. UNOS reports that US hypertensive population. Of the total number of dia-
both patient and graft survival were slightly, though not betic patients reviewed, over 80% had a creatinine deter-
statistically, better among AI/AN than among whites in mination and urinalysis within the past year, and over
Arizona and New Mexico during 1997-1999. 75% had a lipid evaluation. Sixty-three percent of pa-
tients with abnormal protein excretion and 73% of per-
sons with abnormal protein excretion and hypertensionSURVIVAL WITH ESRD
were treated with an angiotensin converting enzyme
Despite socioeconomic barriers and high rates of co- (ACE) inhibitor.
morbid illness, survival among AI/AN ESRD patients The effectiveness of the IHS in achieving this level of
is better than among whites. The USRDS reports a mor- care suggests the potential benefit of approaching kidney
tality rate for prevalent dialysis patients in 1999 of 196.7/ disease using a public health model. Such a model in-
1000 patient-years for whites and 162.4/1000 patient- cludes a multi-disciplinary clinical approach integrated
years for AI/AN. Although the mean albumin of AI/AN with community-based interventions. These interven-
persons starting dialysis from 1995 to 2000 (3.0 g/dL) tions include preventive measures involving environ-
was lower than for whites (3.2 g/dL), body mass index,
mental, educational, and outreach activities, and com-
which also may predict survival, was higher (26.8 kg/m2)
bine with the therapeutic measures into a comprehensive
than for whites (25.8 kg/m2). Survival among AI dialysis
health service delivery system.patients of ESRD Network #15 appears to be better than
USRDS rates. Although network-specific mortality rates
have not been calculated, virtually all of the facilities FUTURE RESEARCH
serving native patients have standardized mortality ratios Even with highly effective intervention programs, the
(SMR) of less than 1.0, several with SMRs much lower. burden of ESRD will continue to increase among AI/AN.
In 2001, the SMRs of the six facilities serving the Navajo AI/AN communities are often considered as subject pop-
Nation range from 0.37 to 0.94. This was particularly ulations for research because they are relatively easy to
remarkable because the mean albumin of all AI/AN identify, have high rates of specific diseases, and are
dialysis patients in Network #15 was 2.81 g/dL, 10% highly endogamous. The epidemic of type 2 diabetes that
lower than the mean of all Network #15 patients, 3.12 g/dL. has affected AI/AN communities for 50 years is now
being duplicated in other “emerging” groups worldwide
and in the populations of highly industrialized countries,PREVENTION/EARLY INTERVENTION
suggesting that AI/AN are not an aberrant group butDiabetes is the predominant cause of the excess bur-
merely “ahead of their time.” The natural history ofden of ESRD among AI/AN, and the IHS has committed
diabetic nephropathy has been well studied in the Pimasignificant resources over the past 30 years to address
Indians and has been utilized in understanding otherdiabetes and its complications. Despite per capita fund-
populations. Native health leaders frequently expressing of only 40% of what is provided for the US civilian
the desire that further efforts will be made to researchpopulation through private insurance and other pro-
effective preventive interventions that will have a similargrams ($1578 vs. $3920/year), the IHS, a public health
wide application.agency providing comprehensive care to AI/AN, has
Some research questions that could be addressed inbeen aggressive in implementing and monitoring optimal
the near future include:care for diabetics at risk for progressive renal disease.
A review of 13,248 charts randomly selected from the
Is there increased susceptibility to non-DM renal in-80,827 persons enrolled in the IHS Diabetes Registry
jury among AI/AN?in 1999 demonstrated that IHS providers were more
Why is the incidence of ESRD increasing among AIsuccessful in achieving benchmarks of clinical care for
women with diabetes?diabetic nephropathy than other large providers [11]. Of
Why is survival on dialysis better for AI/AN than forthe 13,248 patients reviewed, 67% were hypertensive.
Of these, 67% were being treated with an ACE inhibitor; nonAI/AN populations despite low initial albumin?
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